Laplace Interventional Inc. is a medical device company in Plymouth, MN, USA. Laplace Interventional’s investigational device could potentially offer an increase in life expectancy and/or an improvement to quality of life to several patients worldwide diagnosed with Tricuspid Regurgitation (TR). Laplace Interventional is developing a Transcatheter tricuspid valve replacement (TTVR) system that delivers a prosthetic valve percutaneously not requiring an open-heart surgery and thereby reducing future complications in patients.
For general, media and investor enquires, email us at: info@laplaceint.com
Caution: Laplace Interventional's TTVR system is for investigational use only and is NOT currently available for sale in US or any other geography.